|
Volumn 24, Issue 2, 2001, Pages 308-315
|
Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN A1C;
PLACEBO;
ROSIGLITAZONE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG TOLERABILITY;
EDEMA;
FEMALE;
GLUCOSE HOMEOSTASIS;
HEADACHE;
HUMAN;
HYPERGLYCEMIA;
HYPERLIPIDEMIA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
RANDOMIZED CONTROLLED TRIAL;
WEIGHT GAIN;
|
EID: 0035146515
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.24.2.308 Document Type: Article |
Times cited : (277)
|
References (31)
|